Back to Report Store Home

Human Drugs For Veterinary Use – Current Trends and Future Commercial Prospects for Crossover Drugs

  • Published: May-2016
  • Report Code: GBI069CBR
  • Report Format: pdf

Description

Table of Contents

Introduction

The Human and Animal Healthcare Industries

Human Drugs for Veterinary Use: Overview

Regulations for Human Drugs Applied in Veterinary Medicine

Regulation of Human Drugs for Veterinary Use in the US

Extra-Label Drug Use Algorithm

Regulation of Human Drugs for Veterinary Use in Canada

Regulation of Human Drugs for Veterinary Use in the EU

Unmet Needs and Factors Promoting Demand for Human Drugs in the Veterinary Space

Human Drugs Applied in Veterinary Medicine: Case Studies

Lysodren (Mitotane) in Dogs

Fluoxetine hydrochloride (Prozac) in Dogs and Cats

Benazepril (Lotensin, Fortekor) in Dogs and Cats

Quinidine Sulfate in Horses and Dogs

Chemotherapy in Dogs and Cats

Human Drugs for Veterinary Use: Key Marketed Products

Sildenafil

Methimazole

Amlodipine

Phenobarbital

Levothyroxine

Acetaminophen

Hydroxyzine

Humulin N

Pentoxifylline

Bethanechol

Human Prescription and OTC Drugs used in Dogs and Cats

Factors Driving the Crossover Drugs Market

Factors Restraining the Crossover Drugs Market

Key Established Global Players in the Crossover Drugs Market

Zoetis

Boehringer Ingelheim Vetmedica

Merck/MSD Animal Health

Elanco (Eli Lilly)

Merial (Sanofi)

Bayer Animal Health

Emerging Players in the Crossover Drugs Market

Cost-Efficient Business Model for Veterinary Pharmaceutical Companies

Business Models and Crossover Drugs: Examples and Future Focus Areas

Business Strategies Employed by Animal Health Companies with Crossover Drugs

Future Outlook in the Animal Health Market

Bibliography

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$2995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$5990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$8985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards